Company Statement: Galenica and Fresenius Medical Care form a new renal pharmaceutical company
MLex Summary: Health care companies Galenica and Fresenius Medical Care have announced they will set up a new joint venture to develop and commercialise products to treat chronic kidney disease.The full...To view the full article, register now.
Already a subscriber? Click here to view full article